| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MicroRNAs | 21 | 2023 | 53 | 4.960 |
Why?
|
| Gene Expression Regulation, Neoplastic | 17 | 2020 | 55 | 1.830 |
Why?
|
| Cell Movement | 6 | 2024 | 61 | 1.310 |
Why?
|
| Animals | 40 | 2024 | 1711 | 1.300 |
Why?
|
| Breast Neoplasms | 6 | 2023 | 96 | 1.290 |
Why?
|
| Ovarian Neoplasms | 4 | 2019 | 13 | 1.290 |
Why?
|
| Transcription Factors | 9 | 2020 | 66 | 1.270 |
Why?
|
| Neoplasms | 7 | 2024 | 90 | 1.250 |
Why?
|
| Cell Differentiation | 12 | 2024 | 71 | 1.100 |
Why?
|
| Mice | 29 | 2024 | 685 | 1.050 |
Why?
|
| Tumor Suppressor Protein p53 | 7 | 2020 | 29 | 1.050 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2020 | 10 | 1.030 |
Why?
|
| Humans | 47 | 2024 | 4936 | 0.990 |
Why?
|
| RNA, Long Noncoding | 7 | 2021 | 14 | 0.930 |
Why?
|
| Cell Line, Tumor | 18 | 2022 | 160 | 0.920 |
Why?
|
| Signal Transduction | 13 | 2024 | 216 | 0.870 |
Why?
|
| Gene Expression Profiling | 11 | 2022 | 48 | 0.830 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2023 | 1 | 0.800 |
Why?
|
| Cancer Vaccines | 1 | 2023 | 2 | 0.800 |
Why?
|
| Embryonic Stem Cells | 3 | 2013 | 10 | 0.790 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2024 | 39 | 0.770 |
Why?
|
| Cisplatin | 2 | 2019 | 3 | 0.770 |
Why?
|
| Osteosarcoma | 2 | 2019 | 2 | 0.740 |
Why?
|
| RNA, Messenger | 6 | 2021 | 68 | 0.740 |
Why?
|
| Gene Regulatory Networks | 8 | 2018 | 35 | 0.710 |
Why?
|
| Sequence Analysis, RNA | 6 | 2020 | 14 | 0.690 |
Why?
|
| Computational Biology | 2 | 2012 | 32 | 0.650 |
Why?
|
| Transcriptional Activation | 2 | 2019 | 5 | 0.620 |
Why?
|
| Gene Expression Regulation | 8 | 2024 | 73 | 0.610 |
Why?
|
| Female | 19 | 2024 | 2523 | 0.610 |
Why?
|
| Mutation, Missense | 1 | 2019 | 7 | 0.590 |
Why?
|
| Liver Neoplasms | 3 | 2024 | 16 | 0.550 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2020 | 6 | 0.540 |
Why?
|
| Biomarkers, Tumor | 4 | 2017 | 15 | 0.500 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2016 | 1 | 0.480 |
Why?
|
| Cell Proliferation | 11 | 2024 | 115 | 0.480 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2017 | 18 | 0.470 |
Why?
|
| Ribonuclease III | 3 | 2014 | 3 | 0.460 |
Why?
|
| Phosphoproteins | 5 | 2020 | 16 | 0.440 |
Why?
|
| Obesity | 4 | 2021 | 115 | 0.440 |
Why?
|
| Gold | 3 | 2023 | 49 | 0.440 |
Why?
|
| Mice, Knockout | 6 | 2024 | 140 | 0.440 |
Why?
|
| Muscle Development | 3 | 2024 | 13 | 0.430 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2014 | 2 | 0.430 |
Why?
|
| Myoblasts | 2 | 2024 | 10 | 0.410 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2020 | 9 | 0.400 |
Why?
|
| Myocytes, Cardiac | 4 | 2024 | 40 | 0.400 |
Why?
|
| Tretinoin | 1 | 2013 | 3 | 0.400 |
Why?
|
| Chromatin | 1 | 2013 | 7 | 0.400 |
Why?
|
| Skin Neoplasms | 3 | 2020 | 16 | 0.380 |
Why?
|
| Cysteamine | 1 | 2012 | 2 | 0.380 |
Why?
|
| Membrane Proteins | 4 | 2024 | 47 | 0.360 |
Why?
|
| Transcriptome | 5 | 2024 | 43 | 0.350 |
Why?
|
| Muscle, Skeletal | 2 | 2024 | 78 | 0.350 |
Why?
|
| Nanoparticles | 1 | 2012 | 69 | 0.350 |
Why?
|
| Base Sequence | 9 | 2020 | 63 | 0.350 |
Why?
|
| Vocalization, Animal | 1 | 2011 | 1 | 0.340 |
Why?
|
| Finches | 1 | 2011 | 1 | 0.340 |
Why?
|
| Prosencephalon | 1 | 2011 | 2 | 0.340 |
Why?
|
| Auditory Cortex | 1 | 2011 | 3 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 5 | 2024 | 184 | 0.330 |
Why?
|
| Neoplasm Invasiveness | 3 | 2019 | 9 | 0.330 |
Why?
|
| Bacterial Proteins | 3 | 2021 | 56 | 0.330 |
Why?
|
| Neoplastic Stem Cells | 2 | 2016 | 6 | 0.330 |
Why?
|
| Breast | 2 | 2023 | 15 | 0.320 |
Why?
|
| Trans-Activators | 3 | 2020 | 18 | 0.320 |
Why?
|
| Homeodomain Proteins | 4 | 2020 | 7 | 0.320 |
Why?
|
| Pluripotent Stem Cells | 1 | 2009 | 1 | 0.300 |
Why?
|
| Gene Expression | 1 | 2010 | 49 | 0.300 |
Why?
|
| Genes, Tumor Suppressor | 4 | 2018 | 7 | 0.290 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2020 | 29 | 0.280 |
Why?
|
| Mutation | 3 | 2019 | 132 | 0.280 |
Why?
|
| RNA Editing | 1 | 2008 | 2 | 0.280 |
Why?
|
| Stem Cells | 2 | 2019 | 33 | 0.270 |
Why?
|
| Cells, Cultured | 5 | 2021 | 127 | 0.270 |
Why?
|
| Protein Isoforms | 4 | 2024 | 13 | 0.260 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2024 | 4 | 0.250 |
Why?
|
| Precancerous Conditions | 2 | 2017 | 3 | 0.250 |
Why?
|
| RNA-Binding Proteins | 3 | 2016 | 8 | 0.250 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 69 | 0.250 |
Why?
|
| Models, Biological | 3 | 2019 | 124 | 0.240 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2016 | 12 | 0.240 |
Why?
|
| Neuroblastoma | 2 | 2016 | 12 | 0.240 |
Why?
|
| Male | 10 | 2024 | 2491 | 0.230 |
Why?
|
| Lymphoma | 2 | 2016 | 5 | 0.230 |
Why?
|
| Inflammation | 3 | 2021 | 57 | 0.230 |
Why?
|
| Nuclear Proteins | 4 | 2020 | 14 | 0.210 |
Why?
|
| Integrin beta1 | 1 | 2024 | 10 | 0.210 |
Why?
|
| Heart Ventricles | 1 | 2024 | 21 | 0.210 |
Why?
|
| Fibronectins | 1 | 2024 | 13 | 0.210 |
Why?
|
| Extracellular Matrix | 1 | 2024 | 13 | 0.210 |
Why?
|
| Cell Fusion | 1 | 2024 | 5 | 0.210 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2024 | 7 | 0.210 |
Why?
|
| Endoribonucleases | 1 | 2024 | 9 | 0.210 |
Why?
|
| Exosomes | 1 | 2024 | 5 | 0.210 |
Why?
|
| Laminin | 1 | 2024 | 8 | 0.210 |
Why?
|
| Wnt Signaling Pathway | 2 | 2023 | 8 | 0.210 |
Why?
|
| Interferon-gamma | 1 | 2024 | 7 | 0.210 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2024 | 4 | 0.210 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2024 | 5 | 0.210 |
Why?
|
| Sulfonamides | 1 | 2024 | 8 | 0.210 |
Why?
|
| RNA, Small Interfering | 2 | 2014 | 35 | 0.200 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2019 | 22 | 0.200 |
Why?
|
| Oncogenes | 3 | 2019 | 5 | 0.200 |
Why?
|
| TWEAK Receptor | 1 | 2023 | 5 | 0.200 |
Why?
|
| Genes, MHC Class I | 1 | 2023 | 2 | 0.200 |
Why?
|
| Transfection | 2 | 2023 | 15 | 0.200 |
Why?
|
| Metal Nanoparticles | 1 | 2023 | 29 | 0.200 |
Why?
|
| Cell Communication | 1 | 2023 | 14 | 0.200 |
Why?
|
| DNA Methylation | 4 | 2018 | 27 | 0.190 |
Why?
|
| Hepatoblastoma | 1 | 2022 | 1 | 0.190 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2022 | 6 | 0.190 |
Why?
|
| Down-Regulation | 2 | 2019 | 16 | 0.180 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 9 | 0.180 |
Why?
|
| Diet, High-Fat | 2 | 2021 | 34 | 0.180 |
Why?
|
| Disease Models, Animal | 5 | 2022 | 225 | 0.180 |
Why?
|
| Molecular Targeted Therapy | 3 | 2019 | 35 | 0.180 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 25 | 0.180 |
Why?
|
| Molecular Sequence Data | 5 | 2015 | 46 | 0.180 |
Why?
|
| Mice, Nude | 2 | 2019 | 19 | 0.180 |
Why?
|
| Drosophila melanogaster | 2 | 2014 | 45 | 0.180 |
Why?
|
| RNA Nucleotidyltransferases | 2 | 2014 | 3 | 0.180 |
Why?
|
| Prognosis | 5 | 2024 | 60 | 0.180 |
Why?
|
| RNA Stability | 2 | 2014 | 5 | 0.180 |
Why?
|
| Killer Cells, Natural | 2 | 2020 | 32 | 0.180 |
Why?
|
| Epigenesis, Genetic | 3 | 2024 | 27 | 0.170 |
Why?
|
| Gain of Function Mutation | 1 | 2021 | 2 | 0.170 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2021 | 1 | 0.170 |
Why?
|
| Phenylketonurias | 1 | 2021 | 1 | 0.170 |
Why?
|
| Phenylalanine | 1 | 2021 | 3 | 0.170 |
Why?
|
| Curcumin | 1 | 2021 | 10 | 0.170 |
Why?
|
| Antibodies, Bispecific | 1 | 2021 | 1 | 0.170 |
Why?
|
| Oncolytic Virotherapy | 1 | 2021 | 2 | 0.170 |
Why?
|
| Oncolytic Viruses | 1 | 2021 | 2 | 0.170 |
Why?
|
| Simplexvirus | 1 | 2021 | 5 | 0.170 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 19 | 0.170 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2017 | 19 | 0.170 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2021 | 10 | 0.160 |
Why?
|
| Repressor Proteins | 2 | 2017 | 13 | 0.160 |
Why?
|
| DNA Copy Number Variations | 2 | 2018 | 8 | 0.160 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2020 | 5 | 0.160 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2021 | 30 | 0.160 |
Why?
|
| Adenocarcinoma | 1 | 2020 | 10 | 0.160 |
Why?
|
| Software | 2 | 2012 | 57 | 0.160 |
Why?
|
| Up-Regulation | 2 | 2019 | 28 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 3 | 2017 | 27 | 0.160 |
Why?
|
| Histones | 3 | 2017 | 12 | 0.160 |
Why?
|
| Angiotensin II | 1 | 2020 | 13 | 0.160 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2020 | 12 | 0.160 |
Why?
|
| Neural Plate | 1 | 2020 | 2 | 0.160 |
Why?
|
| Body Patterning | 1 | 2020 | 3 | 0.160 |
Why?
|
| Cytomegalovirus | 1 | 2020 | 12 | 0.160 |
Why?
|
| Heart | 2 | 2017 | 48 | 0.160 |
Why?
|
| Gastrula | 2 | 2020 | 4 | 0.160 |
Why?
|
| GTPase-Activating Proteins | 1 | 2019 | 3 | 0.160 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2019 | 3 | 0.160 |
Why?
|
| Heat-Shock Proteins | 1 | 2019 | 5 | 0.150 |
Why?
|
| Micrococcus luteus | 1 | 2019 | 4 | 0.150 |
Why?
|
| Mouse Embryonic Stem Cells | 2 | 2016 | 5 | 0.150 |
Why?
|
| Cytomegalovirus Infections | 1 | 2020 | 25 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 9 | 0.150 |
Why?
|
| Biological Clocks | 1 | 2019 | 9 | 0.150 |
Why?
|
| DNA-Binding Proteins | 3 | 2014 | 22 | 0.150 |
Why?
|
| Stress, Physiological | 1 | 2019 | 26 | 0.150 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 9 | 0.150 |
Why?
|
| Antigen Presentation | 1 | 2019 | 6 | 0.150 |
Why?
|
| Tumor Escape | 1 | 2019 | 4 | 0.150 |
Why?
|
| STAT1 Transcription Factor | 1 | 2019 | 1 | 0.150 |
Why?
|
| Radiation Exposure | 1 | 2019 | 2 | 0.150 |
Why?
|
| Cell Cycle Proteins | 2 | 2016 | 19 | 0.150 |
Why?
|
| Myocardium | 1 | 2019 | 34 | 0.150 |
Why?
|
| Telomerase | 2 | 2016 | 5 | 0.150 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2019 | 17 | 0.150 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 23 | 0.150 |
Why?
|
| Reproducibility of Results | 5 | 2020 | 318 | 0.140 |
Why?
|
| POU Domain Factors | 1 | 2018 | 1 | 0.140 |
Why?
|
| Binding Sites | 1 | 2019 | 66 | 0.140 |
Why?
|
| Protein Binding | 4 | 2021 | 115 | 0.140 |
Why?
|
| Oligonucleotides | 1 | 2018 | 5 | 0.140 |
Why?
|
| Liposomes | 1 | 2019 | 24 | 0.140 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2018 | 1 | 0.140 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2018 | 8 | 0.140 |
Why?
|
| Apoptosis | 5 | 2017 | 46 | 0.140 |
Why?
|
| Palatine Tonsil | 1 | 2018 | 2 | 0.140 |
Why?
|
| Lymphocytes | 1 | 2018 | 8 | 0.140 |
Why?
|
| Disease Progression | 4 | 2020 | 59 | 0.140 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 3 | 0.140 |
Why?
|
| Genital Neoplasms, Female | 1 | 2018 | 3 | 0.140 |
Why?
|
| Nucleic Acid Conformation | 3 | 2021 | 40 | 0.140 |
Why?
|
| Mental Disorders | 1 | 2018 | 48 | 0.140 |
Why?
|
| Methylation | 2 | 2017 | 6 | 0.130 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2017 | 1 | 0.130 |
Why?
|
| Embryo, Mammalian | 3 | 2017 | 30 | 0.130 |
Why?
|
| Polylysine | 1 | 2017 | 6 | 0.130 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2017 | 1 | 0.130 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2017 | 11 | 0.130 |
Why?
|
| CpG Islands | 2 | 2013 | 5 | 0.130 |
Why?
|
| PPAR gamma | 1 | 2016 | 1 | 0.120 |
Why?
|
| Keratosis, Actinic | 1 | 2016 | 1 | 0.120 |
Why?
|
| Actin Cytoskeleton | 1 | 2016 | 11 | 0.120 |
Why?
|
| Stem Cell Transplantation | 1 | 2016 | 6 | 0.120 |
Why?
|
| Myocardial Infarction | 1 | 2016 | 10 | 0.120 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2016 | 2 | 0.120 |
Why?
|
| Brain | 1 | 2018 | 195 | 0.120 |
Why?
|
| Cell Survival | 2 | 2015 | 54 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 11 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2016 | 3 | 0.120 |
Why?
|
| Spheroids, Cellular | 1 | 2016 | 11 | 0.120 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2015 | 3 | 0.120 |
Why?
|
| Smad1 Protein | 1 | 2015 | 1 | 0.120 |
Why?
|
| Xenopus Proteins | 1 | 2015 | 4 | 0.120 |
Why?
|
| Xenopus | 1 | 2015 | 2 | 0.120 |
Why?
|
| Multiple Myeloma | 1 | 2015 | 10 | 0.120 |
Why?
|
| Estradiol | 1 | 2015 | 16 | 0.110 |
Why?
|
| Estrogens | 1 | 2015 | 21 | 0.110 |
Why?
|
| Estrogen Receptor alpha | 1 | 2015 | 22 | 0.110 |
Why?
|
| Annexin A1 | 1 | 2015 | 1 | 0.110 |
Why?
|
| Neoplasms, Basal Cell | 1 | 2015 | 1 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 3 | 0.110 |
Why?
|
| Sequence Alignment | 2 | 2014 | 16 | 0.110 |
Why?
|
| Islet Amyloid Polypeptide | 1 | 2014 | 1 | 0.110 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2014 | 2 | 0.110 |
Why?
|
| X Chromosome | 1 | 2014 | 5 | 0.110 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2014 | 2 | 0.110 |
Why?
|
| Phosphorylation | 3 | 2021 | 48 | 0.110 |
Why?
|
| Sezary Syndrome | 1 | 2014 | 1 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 11 | 1 | 2014 | 1 | 0.110 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2014 | 2 | 0.110 |
Why?
|
| Kidney Neoplasms | 1 | 2014 | 2 | 0.110 |
Why?
|
| Adenine | 1 | 2014 | 3 | 0.110 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2013 | 1 | 0.100 |
Why?
|
| Leukemia | 1 | 2013 | 6 | 0.100 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2013 | 1 | 0.100 |
Why?
|
| CDX2 Transcription Factor | 1 | 2013 | 1 | 0.100 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2013 | 2 | 0.100 |
Why?
|
| Cell Lineage | 3 | 2018 | 15 | 0.100 |
Why?
|
| Databases, Genetic | 3 | 2018 | 7 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 3 | 2017 | 9 | 0.100 |
Why?
|
| Liver | 2 | 2024 | 49 | 0.090 |
Why?
|
| Survival Rate | 3 | 2017 | 14 | 0.090 |
Why?
|
| Genomics | 3 | 2018 | 38 | 0.090 |
Why?
|
| RNA, Plant | 1 | 2012 | 2 | 0.090 |
Why?
|
| Databases, Nucleic Acid | 1 | 2012 | 9 | 0.090 |
Why?
|
| Tumor Microenvironment | 2 | 2024 | 27 | 0.090 |
Why?
|
| Homeobox Protein Nkx-2.5 | 2 | 2024 | 9 | 0.090 |
Why?
|
| Genome-Wide Association Study | 2 | 2024 | 12 | 0.090 |
Why?
|
| Internet | 1 | 2012 | 34 | 0.090 |
Why?
|
| Genetic Loci | 1 | 2011 | 3 | 0.090 |
Why?
|
| Epidermis | 2 | 2024 | 4 | 0.090 |
Why?
|
| Acoustic Stimulation | 1 | 2011 | 17 | 0.090 |
Why?
|
| Adipose Tissue, White | 2 | 2021 | 6 | 0.080 |
Why?
|
| Algorithms | 2 | 2010 | 241 | 0.080 |
Why?
|
| Morphogenesis | 2 | 2024 | 28 | 0.080 |
Why?
|
| Sex Factors | 1 | 2011 | 76 | 0.080 |
Why?
|
| Colorectal Neoplasms | 1 | 2010 | 12 | 0.080 |
Why?
|
| Biomarkers | 2 | 2021 | 81 | 0.080 |
Why?
|
| Proteomics | 2 | 2021 | 19 | 0.080 |
Why?
|
| Mice, Obese | 2 | 2021 | 9 | 0.080 |
Why?
|
| Sense Organs | 1 | 2010 | 2 | 0.080 |
Why?
|
| Microarray Analysis | 1 | 2010 | 8 | 0.080 |
Why?
|
| Multigene Family | 1 | 2009 | 5 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2020 | 14 | 0.070 |
Why?
|
| Primary Cell Culture | 2 | 2020 | 7 | 0.070 |
Why?
|
| Adipocytes | 2 | 2020 | 4 | 0.070 |
Why?
|
| Deoxyuracil Nucleotides | 1 | 2008 | 2 | 0.070 |
Why?
|
| RNA, Small Untranslated | 1 | 2008 | 2 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2018 | 17 | 0.070 |
Why?
|
| Ultraviolet Rays | 2 | 2020 | 29 | 0.070 |
Why?
|
| Embryo, Nonmammalian | 2 | 2020 | 18 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 2 | 2020 | 6 | 0.070 |
Why?
|
| Cell Cycle | 2 | 2017 | 11 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2019 | 11 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2017 | 2 | 0.060 |
Why?
|
| Embryonic Development | 2 | 2017 | 13 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2016 | 9 | 0.060 |
Why?
|
| Mesoderm | 2 | 2016 | 7 | 0.060 |
Why?
|
| DNA Mutational Analysis | 2 | 2016 | 4 | 0.060 |
Why?
|
| MCF-7 Cells | 2 | 2015 | 17 | 0.060 |
Why?
|
| Trialkyltin Compounds | 1 | 2024 | 1 | 0.050 |
Why?
|
| Epigenomics | 1 | 2024 | 1 | 0.050 |
Why?
|
| Endocrine Disruptors | 1 | 2024 | 2 | 0.050 |
Why?
|
| Cell Shape | 1 | 2024 | 9 | 0.050 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2024 | 6 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2024 | 11 | 0.050 |
Why?
|
| Regeneration | 1 | 2024 | 15 | 0.050 |
Why?
|
| Ischemia | 1 | 2024 | 3 | 0.050 |
Why?
|
| Cytosine | 2 | 2014 | 5 | 0.050 |
Why?
|
| Carbon Dioxide | 1 | 2024 | 9 | 0.050 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2024 | 11 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2023 | 7 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2024 | 47 | 0.050 |
Why?
|
| Drosophila Proteins | 2 | 2014 | 30 | 0.050 |
Why?
|
| Dystrophin | 1 | 2021 | 1 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2021 | 9 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 5 | 0.040 |
Why?
|
| Acetylgalactosamine | 1 | 2021 | 1 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2021 | 7 | 0.040 |
Why?
|
| Disease Management | 1 | 2021 | 4 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2021 | 25 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2021 | 18 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2021 | 13 | 0.040 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2021 | 6 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2021 | 23 | 0.040 |
Why?
|
| Diet | 1 | 2021 | 40 | 0.040 |
Why?
|
| Porins | 1 | 2021 | 4 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2020 | 1 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 49 | 0.040 |
Why?
|
| Genome, Bacterial | 1 | 2021 | 21 | 0.040 |
Why?
|
| Mammary Glands, Animal | 1 | 2020 | 5 | 0.040 |
Why?
|
| 3T3-L1 Cells | 1 | 2020 | 2 | 0.040 |
Why?
|
| Receptors, KIR | 1 | 2020 | 1 | 0.040 |
Why?
|
| Diencephalon | 1 | 2020 | 2 | 0.040 |
Why?
|
| Ectoderm | 1 | 2020 | 2 | 0.040 |
Why?
|
| Gastrulation | 1 | 2020 | 2 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 1 | 2020 | 3 | 0.040 |
Why?
|
| Renin-Angiotensin System | 1 | 2020 | 10 | 0.040 |
Why?
|
| Aurora Kinase A | 1 | 2020 | 2 | 0.040 |
Why?
|
| Rhombencephalon | 1 | 2020 | 7 | 0.040 |
Why?
|
| Nervous System | 1 | 2020 | 5 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2020 | 7 | 0.040 |
Why?
|
| Mesencephalon | 1 | 2020 | 9 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2020 | 12 | 0.040 |
Why?
|
| Zebrafish | 1 | 2020 | 20 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2021 | 66 | 0.040 |
Why?
|
| Glyoxylates | 1 | 2019 | 2 | 0.040 |
Why?
|
| Citric Acid Cycle | 1 | 2019 | 5 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2019 | 8 | 0.040 |
Why?
|
| Connexins | 1 | 2019 | 6 | 0.040 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2019 | 2 | 0.040 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2019 | 2 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2019 | 30 | 0.040 |
Why?
|
| Phenylurea Compounds | 1 | 2019 | 3 | 0.040 |
Why?
|
| Anilides | 1 | 2019 | 4 | 0.040 |
Why?
|
| beta Catenin | 1 | 2019 | 7 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 14 | 0.040 |
Why?
|
| Adenoma | 1 | 2019 | 1 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2019 | 20 | 0.040 |
Why?
|
| Pyridines | 1 | 2019 | 23 | 0.040 |
Why?
|
| Quinolines | 1 | 2019 | 21 | 0.040 |
Why?
|
| Gamma Rays | 1 | 2019 | 1 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2019 | 7 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2019 | 8 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2019 | 12 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2019 | 22 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 25 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 14 | 0.040 |
Why?
|
| Postmortem Changes | 1 | 2018 | 2 | 0.040 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 3 | 0.040 |
Why?
|
| Quartz Crystal Microbalance Techniques | 1 | 2018 | 2 | 0.040 |
Why?
|
| Wettability | 1 | 2018 | 6 | 0.040 |
Why?
|
| Sulfur | 1 | 2018 | 4 | 0.040 |
Why?
|
| Photoelectron Spectroscopy | 1 | 2018 | 8 | 0.040 |
Why?
|
| Adipose Tissue, Brown | 1 | 2018 | 3 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2018 | 1 | 0.040 |
Why?
|
| CD56 Antigen | 1 | 2018 | 2 | 0.040 |
Why?
|
| Antigens, CD34 | 1 | 2018 | 3 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2018 | 28 | 0.040 |
Why?
|
| Adsorption | 1 | 2018 | 44 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2018 | 15 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2018 | 8 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2018 | 9 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 6 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2018 | 13 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 14 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2017 | 1 | 0.030 |
Why?
|
| Host Cell Factor C1 | 1 | 2017 | 1 | 0.030 |
Why?
|
| Myosin Heavy Chains | 1 | 2017 | 2 | 0.030 |
Why?
|
| Echocardiography | 1 | 2017 | 9 | 0.030 |
Why?
|
| Cell Line | 1 | 2018 | 84 | 0.030 |
Why?
|
| Bradycardia | 1 | 2017 | 4 | 0.030 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2017 | 1 | 0.030 |
Why?
|
| Diet, Western | 1 | 2017 | 1 | 0.030 |
Why?
|
| Cardiomyopathies | 1 | 2017 | 7 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2017 | 24 | 0.030 |
Why?
|
| Cyclic AMP Response Element-Binding Protein A | 1 | 2017 | 1 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2017 | 27 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 8 | 0.030 |
Why?
|
| Surface Properties | 1 | 2017 | 77 | 0.030 |
Why?
|
| Adipogenesis | 1 | 2016 | 2 | 0.030 |
Why?
|
| Thiazolidinediones | 1 | 2016 | 4 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 5 | 0.030 |
Why?
|
| DNA | 1 | 2017 | 58 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 7 | 0.030 |
Why?
|
| Mice, Hairless | 1 | 2016 | 1 | 0.030 |
Why?
|
| Wnt Proteins | 1 | 2016 | 9 | 0.030 |
Why?
|
| Dogs | 1 | 2016 | 15 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2016 | 3 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2016 | 3 | 0.030 |
Why?
|
| Wnt3A Protein | 1 | 2016 | 3 | 0.030 |
Why?
|
| CELF1 Protein | 1 | 2016 | 2 | 0.030 |
Why?
|
| Integrases | 1 | 2016 | 4 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2016 | 9 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2016 | 8 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 2016 | 6 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 13 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2016 | 7 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 47 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2016 | 7 | 0.030 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2016 | 2 | 0.030 |
Why?
|
| Skin | 1 | 2016 | 26 | 0.030 |
Why?
|
| Ribonucleoside Diphosphate Reductase | 1 | 2015 | 1 | 0.030 |
Why?
|
| bcl-X Protein | 1 | 2015 | 1 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2015 | 7 | 0.030 |
Why?
|
| Cell Death | 1 | 2015 | 18 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2015 | 1 | 0.030 |
Why?
|
| Argonaute Proteins | 1 | 2015 | 1 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 4 | 0.030 |
Why?
|
| Nucleotides | 1 | 2015 | 16 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 33 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2015 | 6 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 18 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 18 | 0.030 |
Why?
|
| Ribosomes | 1 | 2016 | 35 | 0.030 |
Why?
|
| Phenotype | 1 | 2015 | 67 | 0.030 |
Why?
|
| Receptor, ErbB-2 | 1 | 2015 | 17 | 0.030 |
Why?
|
| Tumor Protein p73 | 1 | 2014 | 1 | 0.030 |
Why?
|
| Receptors, Calcitonin | 1 | 2014 | 1 | 0.030 |
Why?
|
| Receptor Activity-Modifying Protein 3 | 1 | 2014 | 1 | 0.030 |
Why?
|
| Thymus Gland | 1 | 2014 | 2 | 0.030 |
Why?
|
| DNA, Satellite | 1 | 2014 | 1 | 0.030 |
Why?
|
| Genes, Lethal | 1 | 2014 | 1 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2014 | 1 | 0.030 |
Why?
|
| Euchromatin | 1 | 2014 | 1 | 0.030 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2014 | 2 | 0.030 |
Why?
|
| Transgenes | 1 | 2014 | 6 | 0.030 |
Why?
|
| Tandem Repeat Sequences | 1 | 2014 | 2 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2014 | 12 | 0.030 |
Why?
|
| Species Specificity | 1 | 2014 | 14 | 0.030 |
Why?
|
| Base Pairing | 1 | 2014 | 9 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2014 | 8 | 0.030 |
Why?
|
| Fallopian Tubes | 1 | 2014 | 1 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2014 | 2 | 0.030 |
Why?
|
| Larva | 1 | 2014 | 10 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2014 | 7 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2014 | 2 | 0.030 |
Why?
|
| Chromosome Breakpoints | 1 | 2014 | 2 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2014 | 2 | 0.030 |
Why?
|
| RNA Interference | 1 | 2014 | 23 | 0.030 |
Why?
|
| Exome | 1 | 2014 | 3 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2014 | 3 | 0.030 |
Why?
|
| Protein Kinase C beta | 1 | 2014 | 3 | 0.030 |
Why?
|
| Exoribonucleases | 1 | 2014 | 2 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2014 | 7 | 0.030 |
Why?
|
| Drosophila | 1 | 2014 | 25 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 14 | 0.030 |
Why?
|
| Genome, Human | 1 | 2014 | 17 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2015 | 161 | 0.030 |
Why?
|
| 5-Methylcytosine | 1 | 2013 | 1 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 6 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2013 | 7 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2013 | 3 | 0.030 |
Why?
|
| Child | 1 | 2016 | 627 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 17 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 17 | 0.020 |
Why?
|
| Kinetics | 1 | 2011 | 80 | 0.020 |
Why?
|
| Wings, Animal | 1 | 2010 | 2 | 0.020 |
Why?
|
| Developmental Biology | 1 | 2010 | 2 | 0.020 |
Why?
|
| Stochastic Processes | 1 | 2010 | 6 | 0.020 |
Why?
|
| Genes, Insect | 1 | 2010 | 8 | 0.020 |
Why?
|
| Biophysics | 1 | 2010 | 15 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2010 | 62 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2010 | 27 | 0.020 |
Why?
|
| Temperature | 1 | 2010 | 60 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2010 | 75 | 0.020 |
Why?
|